MeSH tree: A15.382.670
Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anticancer immune response.
9 hours ago
0
4
Roughly half the world's population is infected with the stomach bacterium Helicobacter pylori, which is responsible for about 90% of gastric cancers. However, until now, it has been unclear why some H. pylori infections ...
Sep 9, 2026
0
219
Breast cancer often grows in tissue that is unusually dense. That's why clinicians flag women with this kind of breast tissue for follow-up after a mammogram.
Sep 8, 2026
0
18
Researchers from Cambridge and Basel have developed small molecules that could make cancer immunotherapies more effective. They work in two ways: they prompt macrophages to engulf cancer cells and alter the surrounding tissue, ...
Sep 8, 2026
0
4
University of Manchester scientists have uncovered a hidden role for immune cells in the womb, opening the door to new treatments for infertility, miscarriage and other reproductive conditions that affect millions of women ...
Sep 8, 2026
0
9
New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow range of cancers, could ...
Sep 5, 2026
0
16
The body's heart muscle (for pumping blood), skeletal muscle (for movement and posture) and brown fat (for heat production) each require a lot of energy and make a lot of waste. That waste needs to be managed.
Sep 4, 2026
0
201
There is a negative link between estimated glucose disposal rate (eGDR) and benign prostatic hyperplasia (BPH) in men, according to a study published online Aug. 25 in The Aging Male.
Aug 31, 2026
0
4
When the sky becomes orange and hazy from wildfire smoke, modern humans are at greater risk than our earlier ancestors would have been.
Aug 26, 2026
0
2
Cornell researchers successfully ramped up the body's own immune response to fight melanoma at the tail end of targeted cancer therapy, when tumors commonly become resistant to these therapies and leave behind residual cancer ...
Aug 24, 2026
0
6
